NERA Insights Webinar | SEP/FRAND Litigation Across Borders

03 September 2020
Hosted By: NERA Economic Consulting

Staying up to date with the similarities and differences of Standard Essential Patent (SEP) and “fair, reasonable, and non-discriminatory” (FRAND) licensing litigation requirements across the world can be a daunting task. Does FRAND licensing have to be a worldwide license? Which regions use the “top-down” approach? In this free, one-hour webinar, held on Thursday, 3 September, at 9:00–10:00 am EDT (9:00–10:00 pm China Standard Time), Associate Director Dr. Sheng Li, Senior Consultant Dr. Claire Chunying Xie, and Steptoe & Johnson Associate Dr. Hui Shen will discuss:

  • Recent examples of FRAND litigation including the recent landmark case Sisvel v. Haier;
  • FRAND licensing litigation requirements across jurisdictions;
  • The relationship between FRAND commitments and economic concerns of hold-up and hold-out problems; and
  • Economic frameworks courts around the world have adopted for assessing FRAND royalties.
View Recording


1 CLE credit hour is approved in New York and California.


Dr. Sheng Li
Associate Director, NERA Economic Consulting

Dr. Claire Chunying Xie
Senior Consultant, NERA Economic Consulting

Dr. Hui Shen
Associate, Steptoe & Johnson

Dr. Sheng Li is an Associate Director in NERA’s Antitrust and Competition Practice, and its Intellectual Property Practice, where he conducts research and economic analysis in antitrust and intellectual property matters. He has evaluated damages theories in cases involving alleged monopolization, exclusive dealing, and price fixing. Dr. Li has also assessed damages arising from patent infringement and issues related to antitrust patent misuse. He has analyzed competitive issues in a variety of industries, including medical devices, auto insurance, transoceanic shipping, and prescription eyewear. He has recently published articles in various publications of the American Bar Association’s Section of Antitrust and has been featured in a legal podcast discussing topics such as big data, artificial intelligence, and life sciences matters. 

Dr. Claire Chunying Xie is a Senior Consultant in NERA’s Antitrust and Competition Practice, and its Intellectual Property Practice, where she conducts economic analysis in the areas of antitrust, intellectual property, and commercial damages. Dr. Xie has evaluated the competitive effects of mergers and acquisitions, and has analyzed antitrust claims and damages in cases involving alleged monopolization and price fixing behaviors in industries such as agriculture, data management, finance, fuel retailing, pharmaceuticals, and telecommunications. Dr. Xie has evaluated damages resulting from patent infringement and breaches of contract in the apparel, credit card, and pharmaceuticals industries.

Dr. Hui Shen represents technology companies in complex intellectual property disputes involving trade secret misappropriation, and patent and copyright infringement. Dr. Shen focuses on patent litigation in federal district courts and the US International Trade Commission (ITC). He is experienced in different stages of litigation. Dr. Shen has a strong technical background in electrical systems, computer software, semiconductor devices, and clean energy technology.


Web Form

To contact us about this event, please click here.